DURHAM, N.C.--(BUSINESS WIRE)--Argos Therapeutics today announced that Dr. Fred Miesowicz, Ph.D., Chief Operating Officer, will present details on the Company’s automated manufacturing process for its Arcelis™ platform, a technology for creating personalized immunotherapies for HIV, other infectious diseases, and cancer. The presentation will take place on August 14, 2008 at the Cambridge Healthtech Institute’s conference on Advances in Cancer Vaccines, part of the ImVacS Immunotherapeutics and Vaccine Summit, in Cambridge, MA.
